首页> 外国专利> Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases

Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases

机译:瓜氨酸和/或另一种一氧化氮前体的靶向肺递送以及在囊性纤维化和其他肺部疾病中一氧化氮肺功能不全的治疗方法

摘要

A method of treatment of cystic fibrosis and other pulmonary diseases identified by nitric oxide deficiency, comprising administration of a nebulized solution of citrulline and/or another nitric oxide precursor as an inhalable aerosol or an inhalable dry powder for targeted delivery into conducting and central airways. Citrulline or another nitric oxide precursor is formulated as a composition having predetermined limited volume, salinity, pH and osmolality. The composition is nebulized into an aerosol having a mass median aerodynamic diameter (MMAD) between 2 μm and 6 μm.
机译:一种治疗由一氧化氮缺乏症所确定的囊性纤维化和其他肺部疾病的方法,包括给予瓜氨酸和/或另一种一氧化氮前体的雾化溶液作为可吸入的气雾剂或可吸入的干粉,以靶向输送至传导和中央气道。瓜氨酸或另一种一氧化氮前体被配制成具有预定的有限体积,盐度,pH和重量克分子渗透摩尔渗透压浓度的组合物。将所述组合物雾化成质量中位数空气动力学直径(MMAD)在2μm至6μm之间的气雾剂。

著录项

  • 公开/公告号US2012076859A1

    专利类型

  • 公开/公告日2012-03-29

    原文格式PDF

  • 申请/专利权人 THOMAS HOFMANN;

    申请/专利号US20100888729

  • 发明设计人 THOMAS HOFMANN;

    申请日2010-09-23

  • 分类号A61K31/197;A61K9/14;A61P11;C07C275/16;

  • 国家 US

  • 入库时间 2022-08-21 17:31:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号